Macroview Investment Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-838
Closed -$42K 459
2022
Q2
$42K Buy
838
+1
+0.1% +$55 0.07% 98
2022
Q1
$51K Hold
837
0.07% 93
2021
Q4
$55K Buy
837
+2
+0.2% +$128 0.07% 89
2021
Q3
$52K Buy
835
+1
+0.1% +$64 0.07% 90
2021
Q2
$50K Hold
834
0.07% 94
2021
Q1
$46K Hold
834
0.07% 86
2020
Q4
$46K Hold
834
0.07% 83
2020
Q3
$42K Buy
834
+744
+827% +$36K 0.07% 82
2020
Q2
$4K Buy
+90
New +$3.85K 0.01% 160

Other funds holding IHI

Macroview Investment Management's IHI Position: Q3 2022 in Review

Macroview Investment Management sold out of iShares US Medical Devices ETF (IHI) in Q3 2022, closing a stake of 838 shares — an estimated $42K sold.

Macroview Investment Management first reported a position in IHI in Q2 2020 and held it in 9 quarters. The position peaked at $55K in Q4 2021. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

  • Macroview Investment Management reported no remaining iShares US Medical Devices ETF position as of Q3 2022 after selling out during the quarter.
  • Macroview Investment Management sold 838 iShares US Medical Devices ETF shares in Q3 2022, an estimated $42K.
  • Macroview Investment Management first reported a position in iShares US Medical Devices ETF in Q2 2020 and held it in 9 quarters.
  • Macroview Investment Management's iShares US Medical Devices ETF position peaked at $55K in Q4 2021.
  • 556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on Macroview Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.